Funding, M&A, exec moves and hiring — every signal, the moment it breaks.See plans →
Salus Scientific closes an oversubscribed Series A financing, raising $10.1 million to fund commercial scale-up and expand production capacity.
PRIVATEAug 05, 2026•2 days ago
Amount Raised
$10.1 Million
Round Type
Series A
CharlestonBiotechnologyDescription
Salus Scientific today announced the successful closing of its oversubscribed Series A financing, raising a total of $10.1 million. The round closed above the initial target of $8.0 million due to strong investor demand. The new capital will support the company's growth and infrastructure development. CEO Todd Flohr expressed excitement about the investor commitment and its alignment with the company's vision.
Related People
Suggested for you
3 contactsVerified contactsCarl, VP hidden hidden hidden
Funding Insights
Based on industry dataTypical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Watching Salus Scientific? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan